刊物主题:Biomedicine Cancer Research Pharmacology and Toxicology Oncology
出版者:Springer Berlin / Heidelberg
ISSN:1432-0843
卷排序:78
文摘
PurposeThe aim of this pilot study is to confirm the safety and efficacy of neoadjuvant therapy and also treatment duration efficacy using modified FOLFIRINOX for patients with borderline resectable pancreatic cancer (BRPC).